Finance

Lists
Why is ACIU up ४.६२%?
Dive Deeper
ACIU:NASDAQ
AC Immune AG
US$ २.७२
+४.६२%
(+०.१२) 1D
सेप्टेम्बर ३०, ११:२२:५५ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACIU...
Open
US$ २.६३
High
US$ २.७४
Low
US$ २.६१
Mkt. cap
२७.६८ करोड
Avg. vol.
१.८८ लाख
Volume
५४.२२ हजार
52-wk high
US$ ४.००
52-wk low
US$ २.१०
EPS
-US$ ०.५२
Beta
१.६०
Shares outstanding
१०.१८ करोड
No. of employees
१०६
Open
US$ २.६३
High
US$ २.७४
Low
US$ २.६१
Mkt. cap
२७.६८ करोड
Avg. vol.
१.८८ लाख
Volume
५४.२२ हजार
52-wk high
US$ ४.००
52-wk low
US$ २.१०
EPS
-US$ ०.५२
Beta
१.६०
Shares outstanding
१०.१८ करोड
No. of employees
१०६
News stories
From web sources and news partners
Zacks
Zacks
·
१ घण्टा पहिले
Here's Why You Should Add URGN Stock to Your Portfolio Now
Zacks
Zacks
·
३ घण्टा पहिले
Best Momentum Stock to Buy for September 30th
Zacks
Zacks
·
२२ घण्टा पहिले
AbbVie Wins FDA Nod for New Parkinson's Disease Drug Juvmo
Zacks
Zacks
·
१ दिन पहिले
KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears
About AC Immune AG
CEOAndrea Pfeifer
Employees१०६
Founded२००३
Headquarters-
Sector-
Websiteacimmune.com
Analyst ratings
Based on 2 analysts giving stock ratings to ACIU in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ACIU in the last 3 months.
Highest
Current US$ २.७२
US$ १२.०० (+३४१.१८%)
Average
US$ १०.०० (+२६७.६५%)
Lowest
US$ ८.०० (+१९४.१२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Fein
H.C. Wainwright
Buy
Maintained
US$ १२.००
+३४१.२%
09/24/2026
Thomas Shrader
BTIG
Buy
Maintained
US$ ८.००
+१९४.१%
08/20/2026
Marc Goodman
Leerink Partners
Buy
Maintained
-
-
04/07/2026
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
९.३९ लाख
३.३८ लाख
११.१९ लाख
१.५१ करोड
Cost of goods sold
१.३१ करोड
१.०६ करोड
१.१७ करोड
१.०५ करोड
Cost of revenue
१.३१ करोड
१.०६ करोड
१.१७ करोड
१.०५ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३५.६७ लाख
४१.९४ लाख
४१.७४ लाख
३५.४० लाख
Operating expense
३५.६७ लाख
४१.२१ लाख
४१.६३ लाख
३४.४४ लाख
Total operating expenses
१.६६ करोड
१.४७ करोड
१.५९ करोड
१.३९ करोड
Operating income
-१.५७ करोड
-१.४४ करोड
-१.४८ करोड
११.९३ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-१.५९ करोड
-१.४४ करोड
-१.४८ करोड
१८.७४ लाख
EBT excluding unusual items
-१.५४ करोड
-१.४४ करोड
-१.४८ करोड
१८.७४ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-७३.०० हजार
-११.०० हजार
-९६.०० हजार
Net income
-१.५९ करोड
-१.४४ करोड
-१.४८ करोड
१८.७४ लाख
Net profit margin
-१,६८८.८२%
-४,२५२.३७%
-१,३२२.७०%
१२.४०%
Earnings per share
-०.१६
-०.१४
-०.१५
०.०२
Interest and investment income
३.६६ लाख
३.५३ लाख
२.२८ लाख
१.७१ लाख
Interest expense
-४६.०० हजार
-४२.०० हजार
-६५.०० हजार
-६१.०० हजार
Net interest expenses
३.२० लाख
३.११ लाख
१.६३ लाख
१.१० लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.५४ करोड
-१.४१ करोड
-१.४४ करोड
१४.६८ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू